Skip to main
AFJK
AFJK logo

AFJK Market Capitalization Overview

Market Cap: $68.38M as of Jun 16, 2025

$68.38M
Past Month+$489.70K (0.72%)
As of Jun 16, 2025, AFJK has a market capitalization of $68.38M. Over the past 30 days, its market cap has increased by 0.95%, while in the last 12 months, it has decreased by -29.2%.

Market capitalization represents the total value of Aimei Health Technology Co Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

AFJK Market Cap Formula = Stock Price * Shares Outstanding

The market cap of AFJK helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

AFJK Market Cap History

DateMarket CapChange
Jun 2, 2025$68.17M+0.95%
May 1, 2025$67.53M-31.97%
Apr 1, 2025$99.27M+0.34%
Mar 3, 2025$98.92M+1.95%
Feb 3, 2025$97.03M+0.19%
Jan 2, 2025$96.85M+1.23%

AFJK End of Year Market Cap History

DateMarket CapChange
2025$68.38M-29.20%
2024$96.58M

FAQs About Aimei Health Technology Co Ltd (AFJK) Market Cap

As of Jun 16, 2025, the market capitalization of AFJK is $68.38M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Aimei Health Technology Co Ltd’s market capitalization has increased by 0.7200%, changing from $67.89M to $68.38M as of Jun 16, 2025.

In the last 3 months, Aimei Health Technology Co Ltd’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Aimei Health Technology Co Ltd’s market capitalization increased from – in January to $96.58M in December, reflecting a — change.

Aimei Health Technology Co Ltd (AFJK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.